Skip to search formSkip to main contentSkip to account menu

VASH2 gene

Known as: FLJ12505, VASH2, VASOHIBIN 2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
A review on vasohibin and ocular neovascularization.
Ischemic and neovascular disease is one of the most difficult ocular diseases to deal with nowadays. Redundancy, poor visual… 
2017
2017
Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
2017
2017
Vasohibin 2 as a potential predictor of aggressive behavior of triple-negative breast cancer.
Triple-negative breast cancer (TNBC) is a subtype breast cancer with aggressive behavior, advanced disease status and poor… 
2017
2017
Angiogenesis and Lymphangiogenesis in Gastric MALT Lymphoma: Relation of VEGF and VASH2
2016
2016
VASH2 induces EMT of cancer cells through both TGF .BETA. dependent and independent pathways
2015
2015
Nuclear vasohibin-2 promotes cell proliferation by inducing G0/G1 to S phase progression.
As a member of the vasohibin (VASH2) family, VASH2 is localized intracellularly as a nuclear and cytoplasmic type. Cytoplasmic… 
2014
2014
Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation
Vasohibin-1 (VASH1) and vasohibin-2 (VASH2), the 2 members of the vasohibin family, have been identified as novel regulators of… 
2013
2013
Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
Vasohibin-2 was recently identified as an important pro-angiogenesis factor in solid tumor and intracellular localization of its… 
Review
2012
Review
2012
The vasohibin family: Novel regulators of angiogenesis.
2009
2009
SF-074-3 Vasohibin 1は,腫瘍の血管新生とリンパ管新生を同時に抑制することで癌の発育,リンパ節転移を抑制する(血管新生・基礎,サージカルフォーラム,第109回日本外科学会定期学術集会)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)